The study involved two thousand teenagers aged 12 to 15 years
The EU regulator has approved for the first time the use of a coronavirus vaccine developed by Pfizer and BioNTech for adolescents aged 12 to 15 years.
This is reported by Swissinfo.
“The EMA’s Medicines Committee has recommended allowing the use of the Comirnaty COVID-19 vaccine in children aged 12 to 15 years,” the report said.
The vaccine showed its 100% effectiveness in a study conducted in the United States with the participation of 2 thousand adolescents aged 12 to 15 years.
Previously, it was possible to vaccinate children against coronavirus only over the age of 16.
Also, recently, Moderna announced that its coronavirus vaccine is safe and effective for adolescents. This is confirmed by the conducted research.
Earlier, the European Medicines Agency (EMA) reported that coronavirus vaccines that use mRNA technology, such as Pfizer/BioNTech and Moderna, are able to “neutralize” the Indian version of COVID-19.